Polymorphic form of 5-chloro-N-{[(5S)-2-oxo-3-[4-(3-oxomor pholin-4-yl)phenyl] oxazolidin5-yl]-methyl}thiophene-2-carboxamide

Details for Australian Patent Application No. 2009335611 (hide)

Owner Apotex Pharmachem Inc

Inventors Bodhuri, Prabhudas; Weeratunga, Gamini

Agent Shelston IP

Pub. Number AU-A-2009335611

PCT Pub. Number WO2010/075631

Priority 12/347,176 31.12.08 US

Filing date 31 December 2009

Wipo publication date 8 July 2010

International Classifications

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/5377 (2006.01)

Event Publications

21 July 2011 PCT application entered the National Phase

  PCT publication WO2010/075631 Priority application(s): WO2010/075631

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009335612-Methods for multiplex analyte detection and quantification

2009335610-Controlled system for the densification of weak soils